Witnessing the stock’s movement on the chart, on Thursday, Axsome Therapeutics Inc (NASDAQ: AXSM) set off with pace as it heaved 22.75% to $182.64, before settling in for the price of $148.79 at the close. Taking a more long-term approach, AXSM posted a 52-week range of $79.19-$158.56.
The Healthcare sector firm’s twelve-monthly sales growth has been -24.44% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -24.44%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 36.56%. This publicly-traded company’s shares outstanding now amounts to $50.31 million, simultaneously with a float of $41.48 million. The organization now has a market capitalization sitting at $9.21 billion. At the time of writing, stock’s 50-day Moving Average stood at $144.32, while the 200-day Moving Average is $119.69.
Axsome Therapeutics Inc (AXSM) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Axsome Therapeutics Inc’s current insider ownership accounts for 17.73%, in contrast to 73.92% institutional ownership. Preceding that transaction, on Dec 02 ’25, Company’s Chief Executive Officer sold 49,252 for 144.59, making the whole transaction’s value amount to 7,121,347. This particular insider is now the holder of 7,229 in total.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Let’s observe the current performance indicators for Axsome Therapeutics Inc (AXSM). It’s Quick Ratio in the last reported quarter now stands at 1.50. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 16.40.
In the same vein, AXSM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.67, a figure that is expected to reach -0.73 in the next quarter, and analysts are predicting that it will be 0.45 at the market close of one year from today.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Going through the that latest performance of [Axsome Therapeutics Inc, AXSM]. Its last 5-days volume of 0.95 million indicated improvement to the volume of 0.69 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 53.66% While, its Average True Range was 84.24.
Raw Stochastic average of Axsome Therapeutics Inc (AXSM) in the period of the previous 100 days is set at 97.85%, which indicates a major rise in contrast to 95.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 5.59 that was higher than 4.43 volatility it exhibited in the past 100-days period.
